arrow
S

Stefanie Eyerich

university of freiburg
H指数:34
被引数:6,060

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Inhibition of RIPK1 prevents keratinocyte cell death and reduces skin inflammation in type 1 mediated chronic inflammatory skin diseases

抑制RIPK1可阻止角质形成细胞死亡,并减少1型介导的慢性炎症性皮肤疾病的皮肤炎症

2026-02-170
OAAI
Neutralizing IL-22RA1 improves histological and molecular alterations associated with atopic dermatitis pathogenesis

中和IL-22RA1改善了与特应性皮炎发病机制相关的组织学和分子改变

2025-11-110
OAAI
Immunopeptidome analysis reveals SERPINB3 as an autoantigen driving eczematized psoriasis

免疫肽组学分析揭示SERPINB3是驱动湿疹样银屑病的自身抗原

2025-10-220
PRE
Tyrosine kinase 2 inhibition improves clinical and molecular hallmarks in subtypes of cutaneous lupus

Wasserer, S.; Seiringer, P.; Kurzen, N.; Jargosch, M.; Eigemann, J.; Aydin, G.; Raunegger, T.; Schmidt-Weber, C.B.; Eyerich, S.; Biedermann, T.; et al. TYK2抑制改善了多种亚型皮肤狼疮的临床及分子标志物。Br. J. Dermatol. 2025, ljaf293. [Google Scholar] [CrossRef]

2025-09-012
PRE
Skin Lipid–Microbe Interplay Links Staphylococcus hominis to Barrier Control in Adult Atopic Dermatitis

皮肤脂质-微生物相互作用将 **Staphylococcus hominis** 与成人特应性皮炎的屏障控制联系起来

2025-08-280
OAAI
Death-Associated Protein Kinase 1 Dampens Keratinocyte Necroptosis and Expression of Inflammatory Genes in Lichen Planus

死亡相关蛋白激酶1减弱扁平苔藓中角质形成细胞的坏死性凋亡和炎症基因的表达

2024-12-310
PRE
Immune modules to guide diagnosis and personalized treatment of inflammatory skin diseases
2024-12-180
OAAI
Pinewood VOC emissions protect from oxazolone-induced inflammation and dysbiosis in a mouse model of atopic dermatitis
2024-10-010
OAAI
Noninferiority of 16-Week vs 8-Week Guselkumab Dosing in Super Responders for Maintaining Control of Psoriasis
2024-09-014
OAAI
Darier's disease exhibits a unique cutaneous microbial dysbiosis associated with inflammation and body malodour (vol 11, 162, 2023)
2023-09-140
OAAI
Gene Expression-Based Molecular Test as Diagnostic Aid for the Differential Diagnosis of Psoriasis and Eczema in Formalin-Fixed and Paraffin-Embedded Tissue, Microbiopsies, and Tape Strips
2023-08-018
OAAI